IL94254A - The competing tricyclicguanides of TH53. - Google Patents

The competing tricyclicguanides of TH53.

Info

Publication number
IL94254A
IL94254A IL9425490A IL9425490A IL94254A IL 94254 A IL94254 A IL 94254A IL 9425490 A IL9425490 A IL 9425490A IL 9425490 A IL9425490 A IL 9425490A IL 94254 A IL94254 A IL 94254A
Authority
IL
Israel
Prior art keywords
indol
thiazole
product
guanidinomethyl
compound
Prior art date
Application number
IL9425490A
Other languages
English (en)
Hebrew (he)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL94254A publication Critical patent/IL94254A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
IL9425490A 1989-05-19 1990-05-02 The competing tricyclicguanides of TH53. IL94254A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,189 US4963689A (en) 1989-05-19 1989-05-19 Heterocyclicguanidines as 5HT3 antagonists

Publications (1)

Publication Number Publication Date
IL94254A true IL94254A (en) 1994-05-30

Family

ID=23371270

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9425490A IL94254A (en) 1989-05-19 1990-05-02 The competing tricyclicguanides of TH53.

Country Status (19)

Country Link
US (1) US4963689A (ko)
EP (1) EP0397364B1 (ko)
JP (1) JPH0635454B2 (ko)
KR (1) KR920003927B1 (ko)
AT (1) ATE92062T1 (ko)
AU (1) AU615385B2 (ko)
CA (1) CA2016182C (ko)
DE (1) DE69002384T2 (ko)
DK (1) DK0397364T3 (ko)
ES (1) ES2058795T3 (ko)
FI (1) FI902291A0 (ko)
HU (1) HUT58063A (ko)
IE (1) IE62935B1 (ko)
IL (1) IL94254A (ko)
MY (1) MY105555A (ko)
NO (1) NO902029L (ko)
NZ (1) NZ233576A (ko)
PT (1) PT93979B (ko)
ZA (1) ZA903478B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140034A (en) * 1989-03-14 1992-08-18 Merck Sharp & Dohme Ltd. Five-membered ring systems with bonded imidazolyl ring substituents
RU2098418C1 (ru) * 1992-09-14 1997-12-10 Яманоути Фармасьютикал Ко., Лтд. Конденсированное производное тиазола или его фармацевтически приемлемая соль, фармацевтическая композиция, проявляющая активность агониста 5-нт*003-рецептора на его основе
WO1995024399A1 (fr) * 1994-03-11 1995-09-14 Yamanouchi Pharmaceutical Co., Ltd. Agoniste de recepteur 5-ht3, nouveau derive de thiazole et intermediaire destine a son obtention
US5887415A (en) * 1995-05-11 1999-03-30 Bernard Matthews Plc Cooked, extruded meat product comprising additive
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
DE102005027193A1 (de) * 2005-06-06 2006-12-07 Wilhelm Stahlecker Gmbh Zwillingseinheit mit zwei Streckwerken für eine Spinnmaschine
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
LT2432467T (lt) 2009-05-20 2018-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonino 5-ht3 receptoriaus antagonistai, skirti panaudoti pažeidimų sukeltų vestibiuliarinių sutrikimų gydymui
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1031165A (en) * 1965-08-18 1966-05-25 Wellcome Found Guanidines, isoureas and isothioureas
GB1305549A (ko) * 1969-10-29 1973-02-07
DE2739723A1 (de) * 1977-09-03 1979-03-08 Merck Patent Gmbh 2-guanidinomethyl-indoline und verfahren zu ihrer herstellung
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4563527A (en) * 1984-07-19 1986-01-07 Torii & Co., Ltd. Amidine compounds

Also Published As

Publication number Publication date
FI902291A0 (fi) 1990-05-08
IE901664L (en) 1990-11-09
US4963689A (en) 1990-10-16
EP0397364A1 (en) 1990-11-14
AU615385B2 (en) 1991-09-26
CA2016182C (en) 1996-03-12
HU902976D0 (en) 1990-09-28
MY105555A (en) 1994-10-31
ES2058795T3 (es) 1994-11-01
NO902029L (no) 1990-11-12
ZA903478B (en) 1991-12-24
AU5476790A (en) 1990-11-15
KR920003927B1 (ko) 1992-05-18
IE62935B1 (en) 1995-03-08
ATE92062T1 (de) 1993-08-15
NO902029D0 (no) 1990-05-08
PT93979B (pt) 1996-11-29
CA2016182A1 (en) 1990-11-09
DE69002384D1 (de) 1993-09-02
HUT58063A (en) 1992-01-28
EP0397364B1 (en) 1993-07-28
PT93979A (pt) 1991-01-08
DE69002384T2 (de) 1993-11-18
JPH0635454B2 (ja) 1994-05-11
NZ233576A (en) 1991-06-25
JPH0311070A (ja) 1991-01-18
KR900018054A (ko) 1990-12-20
DK0397364T3 (da) 1993-09-27

Similar Documents

Publication Publication Date Title
AU656859B2 (en) Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent
AU593278B2 (en) Pharmaceutically active 2-thiomethyl-substituted-1,4- dihydropyridines
JP4890723B2 (ja) TNFαインヒビターとして有用なクマリン誘導体
EP0397365B1 (en) Arylthiazolylimidazoles as 5HT3 Antagonists
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する5−ht3 レセプター拮抗剤
WO2007129111A1 (en) Diazepine derivatives as 5-ht2a antagonists
JP6483700B2 (ja) Tnf活性のモジュレーターとしてのイミダゾチアゾール誘導体
JPH01249769A (ja) 向精神性ヘテロビシクロアルキルピペラジン誘導体
CA2236683A1 (en) Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof
EP0397364B1 (en) Heterocyclic guanidines as 5ht 3 antagonists
HUT65947A (en) Imidazo-pyridine - derivatives with paf/h1 antagonist activity and pharmaceutical compositions containing them and process for the production thereof
US4818760A (en) Derivatives of pyridylsulfinyl(benz-or thieno-)imidazoles and their use as gastric secretion inhibiting substances
TWI325866B (en) Camptothecins with a modified lactone ring
Nagel et al. Heterocyclicguanidines as 5HT 3 antagonists
US5641782A (en) 3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
JPS62230788A (ja) 抗潰瘍剤としての2−〔(2−ピリジル)メチルスルフイニル〕チエノイミダゾ−ル類
CA2030077C (en) Azabicyclo amides and esters as 5-ht _receptor antagonists
PL112834B1 (en) Process for preparing 5-substituted 10,11-dihydro-5h-dibenzo/a,d/cycloheptene-5,10-imines
HUT61760A (en) Process for producing bridged, bicyclic imides comprising 4-/4-(3-benzisothiazolyl)-1-piperazinyl/-butyl group and pharmaceutical compositions comprising such compounds
JPH037227A (ja) 5―ht↓3レセプタ拮抗剤
JPH04234889A (ja) 4H−ピロロ〔1,2−a〕チエノ〔3,2−f〕〔1,4〕ジアゼピンの新規誘導体およびその製造方法
CA2357306A1 (en) Fused ring system containing indole as m4 selective aza-anthracene muscarinic receptor antagonists
FR2640975A1 (ko)
US20040019070A1 (en) Pyrrole-condensed morphinoid derivatives
WO1993012120A1 (en) Pyrazolothiazolopyrimidine derivative

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void